Dr. Kevin Roggin is a board-certified Professor of Surgery and surgical oncologist who specializes in the surgical treatment of complex upper gastrointestinal tract and hepatopancreatobiliary cancers. Dr. Roggin performs advanced robotic HPB procedures, including robotic pancreaticoduodenectomy (Whipple procedure), robotic distal pancreactectomy/splenectomy, robotic liver surgery and robotic gastric surgery. He has helped develop the CDH1 program at the University of Chicago Medicine to evaluate and treat patients and families at risk for hereditary diffuse gastric cancer. _x000D_ Dr. Roggin serves as program director of the General Surgery Residency and associate program director of the Complex General Surgical Oncology Fellowship. He has held leadership positions in the Society of Surgical Oncology (SSO) as the chair of the Training Committee and is currently serving his second three-year term on the SSO Executive Council. He has received numerous teaching awards for his work as an educator and mentor for Pritzker students, UCMC residents and fellows. He developed and implemented the Resident Acute Care Surgical Service (RACS), a novel training paradigm for general surgery residents to promote autonomy and conditional independence with appropriate attending physician supervision._x000D_ Dr. Roggin performs clinical research in pancreatic cancer, sarcoma, and surgical oncology. His recent projects include efforts to apply comprehensive geriatric assessments, sarcopenia measurements, and genomic research to improve the clinical care of patients with pancreatic cancer. He is involved in several multi-institutional projects with the ONNCC and the US Sarcoma Collaborative.